An AI drug discovery company pairing molecular machine learning with physics-based simulation to design small-molecule medicines.
Genesis Therapeutics / University of Texas at Austin
Released October 21, 2025
Structure prediction backbone that swaps AlphaFold3-style triangle attention for triangle multiplication, cutting compute without losing accuracy.